Clinical Trial Update: A Study of the Safety and Effectiveness of an HIV Vaccine for HIV-Positive Patients Receiving Anti-HIV Drugs for at Least 2 Years [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the safety and effectiveness of an HIV vaccine in HIV-positive patients on antiretroviral therapy for at least two year…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 1 | Status: COMPLETED